Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Renin Inhibition on Insulin Sensitivity, Diastolic Function and Aortic Compliance

NCT01252238 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT01252238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01252238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Renin Inhibition on Insulin Sensitivity, Diastolic Function and Aortic Compliance
Lead sponsor
Brigham and Women's Hospital
Phase
Not applicable
Overall status
Terminated
Start date
June 30, 2010
Completion date
December 31, 2012
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic compliance, diastolic function, insulin sensitivity